Aurobindo Pharma Limited has informed the Exchange regarding outcome of Board meeting held on February 09, 2026.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma Limited held a Board meeting on February 9, 2026, and has informed the stock exchange about the outcome. The filing itself is a brief intimation and does not disclose the specific decisions taken at the meeting. Investors will need to refer to the detailed outcome document filed separately on the exchange for the full agenda items, resolutions, and any material announcements. Typically, such board meetings cover matters like financial results, dividends, fundraising, acquisitions, or strategic decisions.
Since the specific outcome is not stated in this intimation, investors should look at the detailed board meeting outcome filing to understand any material impact on the stock. Any major decisions around earnings, dividends, debt, or business expansion could move the share price once disclosed.